UNSPSC 51351632: Estrone hydrogen sulfate

This classification denotes an estrogen with the molecular formula C18H22O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QTL48N278K, chemically known as estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, but more generally known as estrone hydrogen sulfate, which bears US NIH Compound Identifier 699. European Medicines Agency schedules estrone hydrogen sulfate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07251MIG.

Most nations, for tariff purposes, schedule estrone hydrogen sulfate under HS 29372300. SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CCC2=O)OS(=O)(=O)O.

UNSPSC 51351632 Estrone hydrogen sulfate is a Commodity code for a specialized pharmaceutical chemical compound that state and local governments procure for medical and laboratory use. The code covers the purchase of estrone hydrogen sulfate, a pharmaceutical ingredient used in hormone replacement therapies, diagnostic procedures, and medical research applications within public health agencies, hospital systems, and state laboratories. Issuing bodies soliciting under this code include state health departments, county public health offices, municipal hospitals, and academic medical centers that operate within state university systems. The specificity of the commodity means procurement activity is concentrated among jurisdictions with significant clinical laboratory, pharmaceutical, or public health research functions rather than general-purpose municipalities or school districts.

No recent state and local contract opportunities tagged to UNSPSC 51351632 appear in available procurement records. The absence of posted opportunities under this code reflects the narrow, specialized nature of the commodity and the typical procurement patterns of the relatively small number of public-sector buyers with active demand for pharmaceutical-grade estrone hydrogen sulfate. Interested vendors should monitor health-department solicitations and hospital cooperative purchasing vehicles in states with large public hospital networks or research universities, though activity under this specific code is likely to remain sparse and episodic rather than a primary business development focus area.